Journal of Medicinal Chemistry · 2008 · 90 citations · 20 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryLead OptimizationPain MedicineAnalgesic PharmacologyHit-to-lead OptimizationLead Compound DesignOpioid AnalgesicsOpioid PharmacologyPharmacologic Pain TherapyAgonist ActivityAnalgesic Drug DevelopmentDelta Opioid Receptor PharmacologyOpioid Receptor AgonistsPain PharmacologyPharmacologic Management Of PainPharmacologic Pain TreatmentPharmacological Pain Relief
Selective delta opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions. A spirocyclic derivative was identified as a promising hit through screening. Subsequent lead optimization identified compound 20 (ADL5859) as a potent, selective, and orally bioavailable delta agonist. Compound 20 was selected as a clinical candidate for the treatment of pain.
20
The 1996 Guide for the Care and Use of Laboratory Animals
J. Derrell Clark, Gerald F. Gebhart, Janet C. Gonder et al. · ILAR Journal · 1997 · 4.4K citations · Full text
Silvia N. Calderon, Richard B. Rothman, Frank Porreca et al. · Journal of Medicinal Chemistry · 1994 · 217 citations · Full text